Corcept Therapeutics Inc
CORT· Nasdaq
Released Nov 1, 2023, after the close
10-Q filed Nov 1, 2023, 32 days after period end · 0001628280-23-035988
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $123.60M | $101.73M | $96.13M | $86.33M |
| Net Income | $31.38M | $34.61M | $30.47M | $21.63M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.28 |
| $0.30 |
| $0.24 |
| $0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.